Research library
Investment research, in the open.
Research on companies, industries and markets, grounded in official filings and updated as new findings arrive. Free to read.
Recently updated
company · United States
Onto Innovation: Advanced Packaging Metrology and Valuation Analysis
Onto Innovation possesses a clean, net-cash balance sheet and strong strategic exposure to 2.5D/3D advanced packaging and optical critical dimension metrology. In fiscal 2024, the business delivered $987.3 million in revenue and $213.8 million in free cash flow, supported by structural demand for heterogeneous integration and panel-level packaging. However, with trailing multiples remaining elevated, normalized mid-cycle intrinsic value estimates between $115 and $130 per share suggest market pricing already reflects an optimistic super-cycle scenario.
Updated 2026-11-14
company · Mexico
Industrias Bachoco: Operational Moats, Normalized Earnings, and Privatization Dynamics
Industrias Bachoco controls approximately 35% of Mexico's poultry production, underpinned by an extensive cold-chain and live-bird distribution logistics network and a debt-free balance sheet. Controlling shareholders initiated a take-private tender offer at approximately 81.66 MXN per share, representing an EV/EBITDA multiple of 4.0x to 4.5x funded largely by the company's own net cash holdings. Although normalized mid-cycle intrinsic value is appraised between 105 and 118 MXN per local share, delisting and ADR deregistration effectively eliminate public liquidity and minority protections.
Updated 2026-11-14
company · United States
Strategy Inc: Debt Structure Covenants and Bitcoin Liquidation Mechanics
Strategy Inc's debt structure consists primarily of unsecured convertible senior notes that lack mark-to-market loan-to-value margin covenants or price-to-NAV thresholds, meaning equity discounts do not legally force Bitcoin liquidations. Despite negative operating cash flow (-$67.2 million in fiscal 2025) and preferred dividend burdens, the company maintains a dedicated $4.79 billion USD Reserve to service coupons and distributions. Direct asset liquidations would only occur if capital markets remain closed through the 2029–2032 convertible note maturity window after cash reserves are fully exhausted.
Updated 2026-11-13
company · United States
Index Exclusion and Capital Structure Stress: Strategy Inc. Case Study
Strategy Inc.'s removal from MSCI benchmark indexes forces passive funds to execute price-insensitive divestments, shifting market classification of the firm from an operating company to a closed-end asset vehicle. With its stock trading at a compressed 0.9x price-to-book multiple, the reflexive at-the-market equity issuance engine faces dilution constraints, sharply reducing weekly capital generation. Operating cash flow deficits from legacy enterprise software place the burden of servicing fixed debt interest and high-coupon preferred dividends onto existing cash reserves and potential asset sales.
Updated 2026-11-13
company · North America
Strategy Inc.: Capital Structure Stress and Forced Selling Mechanics
Strategy Inc. faces approximately $16.72 billion in cumulative senior claims, comprising $8.25 billion in debt and $8.47 billion in preferred stock notional value, against negative operating cash flows from its software business. While a $2.25 billion cash reserve provides a near-term buffer against immediate insolvency, an ongoing discount to net asset value impairs its primary at-the-market equity financing channel. In severe downturn scenarios where Bitcoin drops toward $25,000 or below, enterprise asset values fall below total senior obligations, eliminating residual common equity value.
Updated 2026-11-13
company · united states
Anthropic's Infrastructure Commitments: Free Cash Flow and Operational Leverage Analysis
Anthropic's aggregate committed spend under purchase commitments and lease agreements escalated to approximately $900.9 billion, with approximately $70.7 billion due over 12 months and $451.6 billion due before year-end 2030. These take-or-pay obligations convert variable compute expenses into massive, non-discretionary fixed cash requirements that mandate true-up payments regardless of actual utilization. Consequently, achieving positive free cash flow demands unprecedented revenue scale to outrun ongoing cash hurdles and continuous hardware reinvestment cycles.
Updated 2026-11-13
company · United States
Anthropic's Compute Purchase Commitments: Hyperscaler Obligations Analysis
Anthropic's regulatory disclosures detail a non-cancelable $121.3 billion hosting commitment with Google through 2033, alongside an estimated $125.0 billion to $150.0 billion in additional TPU procurement through 2031. Across cloud providers and direct lease agreements, aggregate commitments expanded to approximately $900.9 billion as of late 2026. These binding take-or-pay liabilities introduce substantial operating leverage and recycle capital back into hyperscaler cloud platforms.
Updated 2026-11-13
company · United States
Anthropic Valuation Framework: Frontier AI Unit Economics and Fixed Infrastructure Commitments
Anthropic enters the public markets with approximately $114 billion in cash, offset by hundreds of billions in multi-year fixed compute commitments that contribute to a speculative BB+ credit rating. Unlike classical software with zero marginal costs, frontier AI models incur ongoing token inference expenses and rapid R&D depreciation with 12 to 18-month competitive shelf lives. Applying a 9.74% cost of capital and 22% to 25% long-term operating margins yields an estimated intrinsic business value of $1.48 trillion.
Updated 2026-11-13
company · United States
Eli Lilly's Manufacturing Moat: Vertical Integration and Fill-Finish Capex Acceleration
Novo Holdings' buyout of Catalent prompted Eli Lilly to accelerate the verticalization of its sterile fill-finish and peptide manufacturing footprint, reducing reliance on merchant CDMOs. Lilly's capital expenditures increased from $3.45 billion in fiscal 2023 to $7.84 billion in fiscal 2025, reaching $5.26 billion in the first six months of 2026. This internal capacity expansion insulates supply chains, lowers unit production costs relative to vendor pricing, and establishes a durable barrier to entry in commercial GLP-1 scale.
Updated 2026-11-13
company · United States
Eli Lilly Corporate Governance: Board Interlocks and Peptide CDMO Exposure
An examination of Eli Lilly's proxy filings shows that its board of directors maintains complete independence from primary merchant peptide CDMOs. While directors hold leadership roles at industrial and consumer companies such as ADM and Procter & Gamble, none possess overlapping ties to commercial peptide synthesis providers. Furthermore, Lilly's capital allocation strategy prioritizes vertical integration and direct ownership of manufacturing facilities over entangled third-party governance arrangements.
Updated 2026-11-13
company · US
Eli Lilly & Co.: Insider Transactions, Governance Networks, and Strategic Affiliations
An analysis of Eli Lilly's Form 4 filings and proxy disclosures shows insider transactions dominated by routine tax withholdings and selective executive sales alongside significant top-line expansion. The company's board and executive ties link directly to biotechnology platforms such as OmniAb and Alnylam, consumer products leader Procter & Gamble, and technology partner NVIDIA. Concentrated institutional ownership, notably the 9.8% stake held by the Lilly Endowment, provides substantial structural protection as the company scales its cardiometabolic and oncology franchises.
Updated 2026-11-13
company · United States
Catalyst Pharmaceuticals: Agamree Commercial Ramp and Firdapse Patent Vulnerabilities
Agamree cannot offset the financial destruction of a potential early patent cliff on Firdapse, which underpins Catalyst Pharmaceuticals' valuation with an 85.2% gross margin and 43.8% operating margin in fiscal 2025. Agamree faces a multi-year commercial ramp, lower contribution margins due to licensing royalties, and a market ceiling far below Firdapse's cash generation. However, Catalyst's net cash balance sheet and zero debt maturity walls eliminate solvency risk, meaning an adverse legal outcome would represent a valuation impairment rather than a balance-sheet restructuring.
Updated 2026-11-13
company · United States
Catalyst Pharmaceuticals: Patent Litigation Vulnerability and Franchise Durability
Catalyst Pharmaceuticals maintains zero solvency risk due to a net debt to EBITDA ratio of -2.40x and a 0.3% debt-to-capital ratio in fiscal 2025. However, earnings power is heavily reliant on Firdapse, which delivered a 23.1% ROIC, 43.8% operating margins, and supported a $3.85 billion market valuation anchored on exclusivity through February 2035. An unmitigated legal loss against generic filers would compress pricing and margins, though rare-disease commercial infrastructure and clinical guidelines offer partial operational defense.
Updated 2026-11-13
company · United States
NVIDIA Supply Commitments and Purchase Order Structure: Financial Analysis
NVIDIA discloses $92 billion in supply and capacity commitments for the remainder of fiscal 2027 out of a total $279 billion multi-year commitment, but it does not specify the exact dollar amount locked into firm purchase orders. Semiconductor manufacturing lead times of three to five months indicate that near-term tranches are effectively committed to active production. NVIDIA's on-balance-sheet inventory expanded to $31.58 billion, with over $24.7 billion in raw materials and work-in-process, underscoring substantial physical fabrication already underway.
Updated 2026-11-12
company · USA
NVIDIA Leadership Succession: Incentives for Maintaining the Status Quo
NVIDIA's senior leadership team is incentivized to maintain the current leadership structure due to strong financial performance under Jensen Huang, such as $215.94 billion revenue and $120.07 billion net income for the fiscal year ended January 25, 2026. A change in leadership could introduce organizational upheaval, diminish existing power structures, and potentially alter strategic direction, impacting their compensation, influence, and the company's competitive advantage in a fast-paced industry.
Updated 2026-11-12
company · United States
NVIDIA: Governance, Geopolitics, and Key-Person Risk
An investigation into executive conduct and distributor due diligence at NVIDIA highlights corporate governance vulnerabilities and potential export-control tightening across international neocloud customers. While the core technological moat and hardware-software ecosystem remain intact, heightened regulatory scrutiny and the crystallization of key-person risk introduce a valuation multiple discount. Investors must balance strong operational economics against ongoing regulatory audits and succession uncertainties.
Updated 2026-11-12
company · United States
Oracle's Cloud Infrastructure Expansion: Capital Intensity, Financing Structure, and Leverage
Oracle's capital expenditures rose from $4.51 billion in FY 2022 to $55.66 billion in FY 2026, driving free cash flow to negative $23.69 billion. To finance this buildout, the company issued $43.0 billion in senior notes in FY 2026, $5.0 billion in convertible preferred stock, and drew $19.9 billion from an at-the-market common equity program in Q1 FY 2027. This external financing pushed Total Debt to EBITDA to 5.22x and drove quarterly interest expense to $1.43 billion.
Updated 2026-11-12
company · United States
Palantir Technologies: Commercial Acceleration, Asset-Light Margins, and Persistent Share Dilution
Palantir has accelerated enterprise adoption via its Artificial Intelligence Platform (AIP), driving gross margins above 82% and FY2025 free cash flow to $2.10 billion on an asset-light software model. However, operating cash flow remains heavily subsidized by stock-based compensation, which reached $785.7 million in the first nine months of 2026, contributing to a 34% increase in diluted share count since 2021. With the equity trading near 98 times trailing free cash flow alongside decelerating total contract value growth, valuation leaves minimal margin for operational error.
Updated 2026-11-12
company · United States
Broadcom and UCIe: Assessing SerDes Moats and Interconnect Economics
Open Universal Chiplet Interconnect Express (UCIe) standards govern intra-package die-to-die communication rather than the complex long-reach SerDes circuits where Broadcom commands significant pricing power. Although open standards standardize protocol interfaces and lower switching costs for peripheral chiplets, the physical challenges of signal integrity, advanced packaging yields, and high data rates (such as 224G and 448G PAM4) preserve Broadcom's execution premium. Hyperscalers continue to rely on proven physical layer (PHY) implementations to avoid packaging yield failures on multi-die silicon.
Updated 2026-11-12
company · United States
NVIDIA Supply Commitments: Contractual Terms and Downside Exposure
NVIDIA does not disclose a fixed cancellation penalty or liquidated-damages schedule for its $279 billion in supply and capacity obligations. While contracts permit rescheduling or adjustments prior to placing firm orders, changes carry unspecified additional cost liabilities. In practice, the primary financial downside of demand shortfalls manifests as mandatory delivery of customized components leading to inventory write-downs rather than explicit termination fees.
Updated 2026-11-12
company · United States
NVIDIA's $279 Billion Supply Commitments and Hyperscaler Exposure: Contractual Risk Analysis
NVIDIA's regulatory disclosures show that its $279 billion in multi-year supply and capacity commitments are based on internal forecasts rather than downstream customer guarantees. Hyperscalers operate on short, rolling purchase-order windows and maintain no contractual obligation to indemnify NVIDIA against cancelled or delayed demand. Consequently, unabsorbed capacity charges, inventory provisions, and supply obligations remain concentrated on NVIDIA's balance sheet.
Updated 2026-11-12
company · Japan
Nabtesco Corporation: Motion Control Economics and Industrial Automation Moat
Nabtesco Corporation generates the majority of its profits from RV cycloidal precision reduction gears used across heavy industrial robotics, complemented by defensive transport and building door segments. While high engineering tolerances and OEM switching costs protect its dominant market share against emerging Chinese competition, the business remains subject to high capital intensity and capex cyclicality. Consolidated balance sheet discipline and net-cash stability mitigate cyclical earnings swings across broader industrial downcycles.
Updated 2026-11-11